Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0772-2021

Drug recall · September 1, 2021

Atovaquone Oral Suspension recall

Why: Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.

Lots / codes

Batch # 16653A, 16654A, Exp 12/2022

Quantity
1,692 bottles
Company
KVK-Tech, Inc., Newtown, PA
Distribution
Product was distributed to one distributor who may have further distributed Nationwide in the USA.
Initiated
July 2, 2021 · Voluntary: Firm initiated
Classified
August 26, 2021
Reported
September 1, 2021
Ended
May 23, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Atovaquone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.